• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma.

作者信息

Mangiacavalli Silvia, Pochintesta Lara, Cocito Federica, Pompa Alessandra, Bernasconi Paolo, Cazzola Mario, Corso Alessandro

出版信息

Br J Haematol. 2013 Aug;162(4):555-8. doi: 10.1111/bjh.12385. Epub 2013 May 30.

DOI:10.1111/bjh.12385
PMID:23718846
Abstract
摘要

相似文献

1
Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma.多发性骨髓瘤中17P13.1改变的负担与快速进展为浆细胞白血病之间的相关性。
Br J Haematol. 2013 Aug;162(4):555-8. doi: 10.1111/bjh.12385. Epub 2013 May 30.
2
Bortezomib plus melphalan and prednisone for multiple myeloma.硼替佐米联合美法仑和泼尼松治疗多发性骨髓瘤
N Engl J Med. 2008 Dec 11;359(24):2613; author reply 2613-4.
3
Treatment of multiple myeloma: 2009 update.多发性骨髓瘤的治疗：2009年更新
Prescrire Int. 2009 Dec;18(104):263-6.
4
Bortezomib plus melphalan and prednisone for multiple myeloma.硼替佐米联合美法仑及泼尼松治疗多发性骨髓瘤
N Engl J Med. 2008 Dec 11;359(24):2613; author reply 2613-4. doi: 10.1056/NEJMc086420.
5
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.来那度胺和地塞米松联合或不联合硼替佐米治疗复发/难治性多发性骨髓瘤患者：细胞遗传学异常和既往治疗影响的前瞻性评估。
Leukemia. 2010 Oct;24(10):1769-78. doi: 10.1038/leu.2010.175. Epub 2010 Aug 26.
6
Frontline Therapy for Patients with Multiple Myeloma not Eligible for Stem Cell Transplantation.不适用于干细胞移植的多发性骨髓瘤患者的一线治疗
Hematol Oncol Clin North Am. 2014 Oct;28(5):829-38. doi: 10.1016/j.hoc.2014.06.002. Epub 2014 Jul 15.
7
[New treatment strategies for multiple myeloma].[多发性骨髓瘤的新治疗策略]
Rinsho Ketsueki. 2009 Oct;50(10):1506-17.
8
Frontline regimens for multiple myeloma patients.多发性骨髓瘤患者的一线治疗方案。
Clin Adv Hematol Oncol. 2010 May;8(5):331-2.
9
Hepatic extramedullary disease in multiple myeloma with 17p deletion.伴有17p缺失的多发性骨髓瘤中的肝脏髓外疾病
Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):e165-8. doi: 10.1016/j.clml.2014.04.002. Epub 2014 Jun 11.
10
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.硼替佐米-马法兰-泼尼松-沙利度胺序贯硼替佐米-沙利度胺维持治疗与硼替佐米-马法兰-泼尼松方案治疗初治多发性骨髓瘤的随机对照研究
J Clin Oncol. 2010 Dec 1;28(34):5101-9. doi: 10.1200/JCO.2010.29.8216. Epub 2010 Oct 12.

引用本文的文献

1
High-risk multiple myeloma predicted by circulating plasma cells and its genetic characteristics.循环浆细胞预测的高危多发性骨髓瘤及其遗传特征
Front Oncol. 2023 Feb 9;13:1083053. doi: 10.3389/fonc.2023.1083053. eCollection 2023.
2
The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.原发性和继发性浆细胞白血病的细胞遗传学特征：病因发病机制观点、预后影响及与伴有循环克隆性浆细胞差异的新诊断多发性骨髓瘤的临床相关性
Biomedicines. 2022 Jan 19;10(2):209. doi: 10.3390/biomedicines10020209.
3
Clinical and Prognostic Significance of Cell Sensitivity to Chemotherapy Detected in vitro on Treatment Response and Survival of Leukemia Patients.
体外检测的细胞对化疗的敏感性对白血病患者治疗反应和生存的临床及预后意义
J Pers Med. 2019 May 7;9(2):24. doi: 10.3390/jpm9020024.
4
Identification and expression of MMSA-8, and its clinical significance in multiple myeloma.MMSA-8的鉴定、表达及其在多发性骨髓瘤中的临床意义
Oncol Rep. 2017 Jun;37(6):3235-3243. doi: 10.3892/or.2017.5609. Epub 2017 Apr 28.
5
Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma.癌症中p53失调的分子机制：多发性骨髓瘤概述
Int J Mol Sci. 2016 Nov 30;17(12):2003. doi: 10.3390/ijms17122003.
6
p53 abnormalities and potential therapeutic targeting in multiple myeloma.p53 异常与多发性骨髓瘤的潜在治疗靶点。
Biomed Res Int. 2014;2014:717919. doi: 10.1155/2014/717919. Epub 2014 Jun 17.